Our Focus and History
Founded in 2005, Gens & Associates Inc. is a Life Science benchmarking and advisory firm specializing in improving client performance, developing clear and pragmatic strategic plans and implementation roadmaps, and supporting organizational transition.
Our regulatory benchmark data is the industry standard – quoted by industry analysts, software and service providers, thought leaders and utilized extensively by industry.
Company Milestones
World Class RIM℠
Over 100 Life Science Organizations have participated in our World Class RIM benchmark that provides the only industry peer comparison with the latest survey data on peer investments, process and organizational improvement plans, and the RIM Software and Services Provider Landscape. Whether you are modernizing your capability or rethinking your approach, our deep RIM strategy and planning services coupled with our regulatory knowledge and RIM benchmarks are unparalleled.
Learn More
Benchmark Premier Membership
We started our invite-only Premier Membership Program in the fall of 2019 that combines our strategic performance improvement advisory service, with access to our private survey content and market reports through our Executive Lounge.
Learn More
Steve Gens | Gens & Associates Founder
In the summer of 2005, I founded Gens & Associates Inc., a virtual consulting firm that serves the global Life Sciences industry. The office consisted of a folding table, chair, laptop and cell phone in a spare room of my home. Today it is a leading independent boutique management and organizational consultancy that provides advisory consulting services and a world-renowned regulatory benchmark serving over 100 Life Sciences organizations annually.
The company’s mission is to help all stakeholders in the regulatory eco-system accelerate global transformation, increase efficiency and organizational agility to shorten approvals of effective new drugs and contribute to medicine affordability. We do this through strategic leadership, enhancing industry standards, collaboration, and providing deep insights derived from our highly respected research platform, to identify the most effective investments for improved outcomes.